Trastuzumab

Rediff.com » News » Trastuzumab

News for Trastuzumab

News
Business

Govt cuts customs duty on 3 cancer drugs

The government on Tuesday proposed to fully exempt three cancer medicines from customs duties. The government proposes to cut customs duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab......

What Sitharaman's 7th Budget has in store for us

Highlights of the Union Budget 2024-25 presented by Finance Minister Nirmala Sitharaman in Lok Sabha on Tuesday. Illustration: Dominic Xavier/Rediff.com Standard deduction in new tax regime......

Budget 2024: What is cheaper, what is costlier

Gold, silver and other precious metals along with imported mobile phones, certain cancer drugs and medical devices are set to become cheaper with Finance Minister Nirmala Sitharaman announcing cuts......

'Expect formulations biz to outpace API biz'

'API prices are dragging down margins and impacting our competitive ability.' Photograph: Kind courtesy Biocon Biocon delves into the evolving dynamics of the biosimilar market, with a focus on......

Biocon Biologics Plan Molecule Launch Every 1-2 Years

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.' Photograph: PTI Photo The market share that Biocon......

Biocon contests Roche claims on cancer drug

Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing its new drug, co-developed with Mylan, as a......

Rediff News

Trastuzumab

News for Trastuzumab

Govt cuts customs duty on 3 cancer drugs

What Sitharaman's 7th Budget has in store for us

Budget 2024: What is cheaper, what is costlier

'Expect formulations biz to outpace API biz'

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon contests Roche claims on cancer drug

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS